Announcement, Press Release | 04.14.26 Parker Institute for Cancer Immunotherapy and Cancer Vaccine Coalition Unite to Accelerate Cancer Prevention and Treatment as Momentum Builds for Cancer Vaccines
Announcement, Press Release | 03.26.26 Parker Institute for Cancer Immunotherapy Appoints Bolyn Hubby as Chief of Staff to Strengthen Organization Excellence During Period of Growth
Announcement, Press Release | 02.25.26 Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer
Announcement, Press Release | 01.28.26 Parker Institute for Cancer Immunotherapy Collaborates with Conquer Cancer and ASCO to Support Promising Cancer Research
Announcement, Press Release | 11.04.25 Parker Institute for Cancer Immunotherapy Demonstrates Leadership and Showcases Latest Advances in Immunotherapy at SITC 2025 Annual Meeting
Announcement, Press Release | 09.19.25 The Parker Institute for Cancer Immunotherapy Awards Over $1 Million to Five Early Stage Career Researchers Pushing the Boundaries of Cancer Science
Announcement, Our Impact, Press Release | 05.28.25 ASCO 2025: In a Defining Era for Oncology, PICI Drives Patient Impact Forward
Announcement, Partner Highlight, Press Release | 05.28.25 Lumanity to Support Translation of PICI’s Breakthrough Science with Go-to-Market Expertise
Announcement, Partner Highlight, Press Release | 04.24.25 Immunai and the Parker Institute Collaborate to Build One of the Largest Single-Cell Datasets in Cancer
Announcement, Press Release | 04.10.25 Parker Institute Appoints Renowned Cancer Immunologist Dr. Ira Mellman as President of Research
Announcement, Press Release | 03.31.25 Karen Knudsen, MBA PhD, Appointed Chief Executive Officer of the Parker Institute for Cancer Immunotherapy
Announcement, Press Release | 11.19.24 Parker Institute Awards $525,000 to Advance Talent in Cancer Research